The DOI matches its Crossref record; 166 of the 167 references it cites were found in a registry or an index.
Critical roles of non-histone protein lysine methylation in human tumorigenesis
Abstract
Several protein lysine methyltransferases and demethylases have been identified to have critical roles in histone modification. A large body of evidence has indicated that their dysregulation is involved in the development and progression of various diseases, including cancer, and these enzymes are now considered to be potential therapeutic targets. Although most studies have focused on histone methylation, many reports have revealed that these enzymes also regulate the methylation dynamics of non-histone proteins such as p53, RB1 and STAT3 (signal transducer and activator of transcription 3), which have important roles in human tumorigenesis. In this Review, we summarize the molecular functions of protein lysine methylation and its involvement in human cancer, with a particular focus on lysine methylation of non-histone proteins.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The mechanisms that underpin these adaptive responses and render epigenetic therapies ineffective are varied and include tumour-intrinsic mechanisms and heterogenous cellular and molecular effects of the drugs 187 .”
From The roles of DNA, RNA and histone methylation in ageing and cancer (2019) · cites this paper as [187]
Citations
Cites
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,951
Mutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1
Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., Casero, R. A., & Shi, Y. (2004) · Cell · doi:10.1016/j.cell.2004.12.012 · Cited by 4,051
VEGF receptor signalling ? in control of vascular function
Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1911 · Cited by 3,122
Regulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845
The mutational landscape of lethal castration-resistant prostate cancer
Grasso, C. S., Wu, Y.-M., Robinson, D. R., Cao, X., Dhanasekaran, S. M., Khan, A. P., Quist, M. J., Jing, X., Lonigro, R. J., Brenner, J. C., et al. (2012) · Nature · doi:10.1038/nature11125 · Cited by 2,517
HSP90 and the chaperoning of cancer
Whitesell, L., & Lindquist, S. L. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1716 · Cited by 2,502
Histone demethylation by a family of JmjC domain-containing proteins
Tsukada, Y.-I., Fang, J., Erdjument‐Bromage, H., Warren, M., Borchers, C. H., Tempst, P., & Zhang, Y. (2005) · Nature · doi:10.1038/nature04433 · Cited by 2,244
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
McCabe, M. T., Ott, H. M., Ganji, G., Korenchuk, S., Thompson, C., Van Aller, G. S., Liu, Y., Graves, A. P., III, A. D. P., Diaz, E., et al. (2012) · Nature · doi:10.1038/nature11606 · Cited by 1,786
The HSP70 chaperone machinery: J proteins as drivers of functional specificity
Kampinga, H. H., & Craig, E. A. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2941 · Cited by 1,760
Flagged first, then by citations
1 of the 167 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Clarke, S. G. & Tamanoi, F. (eds) The Enzymes: Protein Methyltransferases Vol. 24 (Academic Press, 2006).
Cited by
Sorted by citations
Items 201–300 of 387
Wang, Z., & Liu, H. (2024) · Biomolecules · doi:10.3390/biom14070862 · Cited by 14
Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axis
Signorile, M. L., Nicola, E. D., Forte, G., Sanese, P., Fasano, C., Disciglio, V., Marco, K. D., Latrofa, M., Cecco, L. D., Ficorilli, M., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02290-z · Cited by 15
An Information Entropy-Based Approach for Computationally Identifying Histone Lysine Butyrylation
Huang, G., Zheng, Y., Wu, Y., Han, G., & Yu, Z. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2019.01325 · Cited by 14
Xu, Y., Fan, B., Gao, Y., Chen, Y., Han, D., Lu, J., Liu, T., Gao, Q., Zhang, J. Z. H., & Wang, M. (2022) · Molecules · doi:10.3390/molecules27238358 · Cited by 14
Vougiouklakis, T., Nakamura, Y., & Saloura, V. (2017) · Epigenetics · doi:10.1080/15592294.2017.1391430 · Cited by 14
Self-citationPrevalence of Enhancer of Zeste Homolog 2 in Patients with Resected Small Cell Lung Cancer
Toyokawa, G., Takada, K., Tagawa, T., Kinoshita, F., Kozuma, Y., Matsubara, T., Haratake, N., Takamori, S., Akamine, T., Hirai, F., et al. (2018) · Anticancer Research · doi:10.21873/anticanres.12649 · Cited by 14
Self-citationEpigenetic Mechanisms Underlying COVID-19 Pathogenesis
Kaneko, S., Takasawa, K., Asada, K., Shinkai, N., Bolatkan, A., Yamada, M., Takahashi, S., Machino, H., Kobayashi, K., Komatsu, M., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9091142 · Cited by 13
Self-citationZhu, H.-P., Chai, J., Qin, R., Leng, H., Wen, X., Peng, C. M., He, G., & Han, B. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.115009 · Cited by 13
Chandramouli, B., & Chillemi, G. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00652 · Cited by 13
RNA-seq based transcriptome analysis of EHMT2 functions in breast cancer
Kim, K., Ryu, T. Y., Ryu, J., Han, T.-S., Jung, C., Son, M., Kim, D., & Cho, H. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.01.128 · Cited by 13
Polycomb Paralog Chromodomain Inhibitors Active against Both CBX6 and CBX8**
Milosevich, N., Wilson, C. R., Brown, T. M., Alpsoy, A., Wang, S., Connelly, K. E., Sinclair, K. A. D., Ponio, F., Hof, R., Dykhuizen, E. C., et al. (2021) · ChemMedChem · doi:10.1002/cmdc.202100262 · Cited by 13
Huang, Y., Ting, P. Y., Yao, T. M., Homma, T., Brooks, D. L. P., Rangel, I. K., Adler, G. K., Romero, J. R., Williams, J. S., Pojoga, L. H., et al. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0247 · Cited by 13
Li, X., Song, D., Chen, Y., Huang, C., Liu, A., Wu, Q., She, X., Li, K., Wan, K., Yu, C., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113126 · Cited by 12
A Chemoselective Enrichment Strategy for In‐Depth Coverage of the Methyllysine Proteome
Yan, L., Zheng, M., Fan, M., Yao, R., Zou, K., Feng, S., & Wu, M. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202408564 · Cited by 13
Fan, Y., Qian, X., & Zhang, C. (2016) · Tumor Biology · doi:10.1007/s13277-016-5352-z · Cited by 12
Genomics and advances towards precision medicine for head and neck squamous cell carcinoma
Waes, C. V., & Musbahi, O. (2017) · Laryngoscope Investigative Otolaryngology · doi:10.1002/lio2.86 · Cited by 12
Structural basis for antigen recognition by methylated lysine–specific antibodies
Ishii, M., Nakakido, M., Caaveiro, J. M. M., Kuroda, D., Okumura, C. J., Maruyama, T., Entzminger, K. C., & Tsumoto, K. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015996 · Cited by 12
Yadav, A. K., & Singh, T. R. (2021) · Molecular Simulation · doi:10.1080/08927022.2021.1957882 · Cited by 12
The Organelle-Specific Regulations and Epigenetic Regulators in Ferroptosis
Zhang, Y., Li, M., Guo, Y., Liu, S., & Tao, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.905501 · Cited by 12
The Prognostic Impact of Jumonji Domain-containing 2B in Patients with Resected Lung Adenocarcinoma
Toyokawa, G., Taguchi, K., Edagawa, M., Shimamatsu, S., Toyozawa, R., Nosaki, K., Hirai, F., Yamaguchi, M., Shimokawa, M., Seto, T., et al. (2016) · Anticancer Research · doi:10.21873/anticanres.11046 · Cited by 12
Self-citationOuter Membrane Protein OmpB Methylation May Mediate Bacterial Virulence
Yang, D. C. H., Abeykoon, A. H., Choi, B.-E., Ching, W., & Chock, P. B. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.09.005 · Cited by 12
Zuo, Y., Hong, Y., Zeng, X., Zhang, Q., & Liu, X. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac277 · Cited by 11
Lysine Methylation-Dependent Proteolysis by the Malignant Brain Tumor (MBT) Domain Proteins
Sun, H., & Zhang, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042248 · Cited by 11
Methylation of ESCRT-III components regulates the timing of cytokinetic abscission
Richard, A., Berthelet, J., Judith, D., Advedissian, T., Espadas, J., Jannot, G., Amo, A., Loew, D., Lombard, B., Casanova, A. G., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47717-3 · Cited by 11
Luo, Y., Lu, J., Lei, Z., Zhu, H., Rao, D., Wang, T., Fu, C., Zhang, Z., Xia, L., & Huang, W. (2024) · Biomarker Research · doi:10.1186/s40364-024-00621-w · Cited by 12
Murali, M., Saeed, A., Kim, S., Burkitt, K., Cheng, H., Moshiri, A., Akhtar, J., Tsai, D., Luff, M. K., Karim, B. O., et al. (2025) · Scientific Reports · doi:10.1038/s41598-024-83396-2 · Cited by 11
Self-citationToyokawa, G., Takada, K., Okamoto, T., Kozuma, Y., Matsubara, T., Haratake, N., Akamine, T., Takamori, S., Katsura, M., Shoji, F., et al. (2017) · Anticancer Research · doi:10.21873/anticanres.11461 · Cited by 11
Self-citationSohtome, Y., Shimazu, T., Barjau, J., Fujishiro, S., Akakabe, M., Terayama, N., Dodo, K., Ito, A., Yoshida, M., Shinkai, Y., et al. (2018) · Chemical Communications · doi:10.1039/c8cc03907k · Cited by 11
Insights into novel emerging epigenetic drugs in myeloid malignancies
Chandhok, N. S., & Prébet, T. (2019) · Therapeutic Advances in Hematology · doi:10.1177/2040620719866081 · Cited by 11
Piao, L., Yuan, X., Wang, L., Xu, X., Zhuang, M., Li, J., Kong, R., & Liu, Z. (2020) · Oncology Letters · doi:10.3892/ol.2020.11887 · Cited by 11
Kim, G., Jang, G., Song, J., Kim, D., Lee, S., Joo, J. W. J., & Jang, W. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274879 · Cited by 11
Probing the interaction of the p53 C-terminal domain to the histone demethylase LSD1
Speranzini, V., Ciossani, G., Marabelli, C., & Mattevi, A. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.07.021 · Cited by 11
Sohtome, Y., & Sodeoka, M. (2018) · The Chemical Record · doi:10.1002/tcr.201800118 · Cited by 11
Li, Y., Sun, B., Xu, L., Chen, L., & Ou, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147416 · Cited by 11
A Genetically Encoded Allysine for the Synthesis of Proteins with Site‐Specific Lysine Dimethylation
Wang, Z. A., Zeng, Y., Kurra, Y., Wang, X., Tharp, J. M., Vatansever, E. C., Hsu, W. W., Dai, S. Y., Fang, X., & Liu, W. R. (2016) · Angewandte Chemie · doi:10.1002/ange.201609452 · Cited by 11
Histone methyltransferase SUV39H2 serves oncogenic roles in osteosarcoma
Piao, L., Yuan, X., Zhuang, M., Qiu, X., Xu, X., Kong, R., & Liu, Z. (2018) · Oncology Reports · doi:10.3892/or.2018.6843 · Cited by 11
Fine-tuning AKT kinase activity through direct lysine methylation
Guo, J., & Wei, W. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1609832 · Cited by 12
SETD6 mediates selective interaction and genomic occupancy of BRD4 and MITF in melanoma cells
Biton, T. E., Feldman, M., Davidy, T., Moskovitz, N. T., Levin, L., Sevilla-Sánchez, D., Goding, C. R., Bernstein, E., & Levy, D. (2025) · NAR Cancer · doi:10.1093/narcan/zcaf023 · Cited by 10
Wang, K., Zhang, L., Zhang, S., Liu, Y., Mao, J., Liu, Z., Xu, L., Li, K., Wang, J., Ma, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51979-2 · Cited by 10
Coelho, P. D. O., Guarnier, F. A., Figueiredo, L. B., Zaramela, L. S., Pacini, E. S. A., Godinho, R. O., & Gomes, M. D. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.01.009 · Cited by 10
Yao, S., Wang, X., Guo, Z. G., & Wang, J. (2020) · Oncogene · doi:10.1038/s41388-020-01446-1 · Cited by 10
Sun, J., Li, Z., & Yang, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137185 · Cited by 10
Proteome-wide identification of non-histone lysine methylation in tomato during fruit ripening
Xiao, L., Liang, H., Jiang, G., Ding, X., Liu, X., Sun, J., Jiang, Y., Song, L., & Duan, X. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.02.013 · Cited by 10
Zhang, Z., Freeman, M. D., Zhang, Y., El‐Nachef, D., Davenport, G., Williams, A. L., & MacLellan, W. R. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281610 · Cited by 10
Shard, A., Rawat, K., Sinha, A. K., Padwad, Y. S., & Kumar, D. (2016) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201601104 · Cited by 10
Zhang, P., Ruan, J., Weng, W., & Tang, Y. (2019) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2019.1675875 · Cited by 10
The role of SET domain containing lysine methyltransferase 7 in tumorigenesis and development
Yang, S., Wang, X., Bai, J., & Duan, B. (2022) · Cell Cycle · doi:10.1080/15384101.2022.2122257 · Cited by 9
Markouli, M., Strepkos, D., & Piperi, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113657 · Cited by 9
RetractedDMSO‐Related Effects on Ligand‐Binding Properties of Lysine Methyltransferases G9a and SETD8
Feoli, A., Sarno, G., Castellano, S., & Sbardella, G. (2024) · ChemBioChem · doi:10.1002/cbic.202300809 · Cited by 9
Versatile and efficient chromatin pull-down methodology based on DNA triple helix formation
Isogawa, A., Fuchs, R. P., & 藤井, 慎. (2018) · Scientific Reports · doi:10.1038/s41598-018-24417-9 · Cited by 9
Characterization of Squamous Cell Lung Cancers from Appalachian Kentucky
Liu, J., Murali, T., Yu, T., Liu, C., Sivakumaran, T. A., Moseley, H., Zhulin, I. B., Weiss, H. L., Durbin, E. B., Ellingson, S. R., et al. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-0984 · Cited by 9
Johnson, T. B., Payne, S., Grove, R. A., McCarthy, S., Oeltjen, E., Mach, C., Adamec, J., Wilson, M. A., Cott, K. E. V., & Blum, P. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006469 · Cited by 9
Conformational Selection in Ligand Recognition by the First Tudor Domain of PHF20L1
Lv, M., Gao, J., Li, M., Ma, R., Li, F., Liu, Y., Liu, M., Zhang, J., Yao, X., Wu, J., et al. (2020) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.0c02039 · Cited by 9
Synthesis and structure–activity relationship studies of LLY-507 analogues as SMYD2 inhibitors
Zhang, B., Liao, L., Wu, F., Zhang, F., Sun, Z., Chen, H., & Luo, C. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127598 · Cited by 9
Investigation of H2 AX methylation by the SUV 39H2 protein lysine methyltransferase
Schuhmacher, M. K., Kudithipudi, S., & Jeltsch, A. (2016) · FEBS Letters · doi:10.1002/1873-3468.12216 · Cited by 10
The Role of Chromatin-Associated Proteins in Cancer
Helin, K., & Minucci, S. (2016) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-050216-034422 · Cited by 9
Yu, Y., Herrmann, A., Thonn, V., Cordsmeier, A., Neurath, M. F., Ensser, A., & Becker, C. (2022) · Cells · doi:10.3390/cells11081262 · Cited by 9
Inoue, F., Sone, K., Kumegawa, K., Hachijo, R., Suzuki, E., Tanimoto, S., Tsuboyama, N., Kato, K., Toyohara, Y., Takahashi, Y., et al. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5620 · Cited by 8
Warmerdam, Z., Kamba, B. E., Le, M., Schrader, T. H., Isaacs, L., Bayer, P., & Hof, F. A. (2021) · ChemBioChem · doi:10.1002/cbic.202100502 · Cited by 8
Histone methyltransferase SUV420H1 / KMT5B contributes to poor prognosis in hepatocellular carcinoma
Kato, H., Hayami, S., Ueno, M., Suzaki, N., Nakamura, M., Yoshimura, T., Miyamoto, A., Shigekawa, Y., Okada, K., Miyazawa, M., et al. (2023) · Cancer Science · doi:10.1111/cas.16038 · Cited by 7
Self-citationNisio, E. D., Manzini, V., Licursi, V., & Negri, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136900 · Cited by 7
Sanese, P., Fasano, C., Signorile, M. L., Marco, K. D., Forte, G., Disciglio, V., Grossi, V., & Simone, C. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189203 · Cited by 8
Micallef, I., Fenech, K., & Baron, B. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1455415 · Cited by 7
Yadav, A. K., & Singh, T. R. (2023) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-023-00594-7 · Cited by 7
Phenotypic characterization of SETD3 knockout Drosophila
Tiebe, M., Lutz, M., Levy, D., & Teleman, A. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201609 · Cited by 7
Lysine methylation regulates nervous system diseases
Wang, Z., & Liu, H. (2019) · Neuropeptides · doi:10.1016/j.npep.2019.04.004 · Cited by 7
Protein arginine methyltransferases as regulators of cellular stress
Zaccarelli‐Magalhães, J., Citadin, C. T., Langman, J., Smith, D. J., Matuguma, L. H., Lin, H. W., & Udo, M. S. B. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115060 · Cited by 6
Chopra, A., Adhikary, H., Willmore, W. G., & Biggar, K. K. (2019) · Current Protein and Peptide Science · doi:10.2174/1389203721666191231104225 · Cited by 7
Structure-function conservation between the methyltransferases SETD3 and SETD6
Admoni-Elisha, L., Abaev-Schneiderman, E., Cohn, O., Shapira, G., Shomron, N., Feldman, M., & Levy, D. (2022) · Biochimie · doi:10.1016/j.biochi.2022.05.003 · Cited by 6
Epigenetic Mechanisms in Head and Neck Cancer
Osorio, J. C., & Castillo, A. (2016) · InTech eBooks · doi:10.5772/61135 · Cited by 7
Identification and functional characterization of lysine methyltransferases of Entamoeba histolytica
Borbolla‐Vázquez, J., Orozco, E., Medina‐Gómez, C., Martínez‐Higuera, A., Javier‐Reyna, R., Chávez, B., Betanzos, A., & Rodríguez, M. A. (2016) · Molecular Microbiology · doi:10.1111/mmi.13394 · Cited by 6
Clinical Perspective of Posttranslational Modifications
Kawa, I. A., Masood, A., Amin, S., Mustafa, M. F., & Rashid, F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811913-6.00002-3 · Cited by 7
The post translational modification of key regulators of ATR signaling in DNA replication
Chen, Y., & Yuan, J. (2021) · Genome Instability & Disease · doi:10.1007/s42764-021-00036-z · Cited by 6
Pan, Y., Yan, C., Hu, Y., Fan, Y., Pan, Q., Wan, Q., Torcivia-Rodriguez, J., & Mazumder, R. (2017) · Scientific Reports · doi:10.1038/srep42169 · Cited by 6
The molecular genetics of adrenal cushing
Vaduva, P., & Bertherat, J. Y. (2024) · HORMONES · doi:10.1007/s42000-024-00608-0 · Cited by 5
Regulation of autophagy and cellular signaling through non-histone protein methylation
Bao, Y., Ma, Y., Huang, W., Bai, Y., Gao, S., Xiu, L., Xie, Y., Wan, X., Shan, S., Chen, C., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.139057 · Cited by 5
Lv, Y., Feng, Y., Lu, J., Zhang, S., Wei, Y., & Gao, C. (2025) · Animal nutrition · doi:10.1016/j.aninu.2025.04.008 · Cited by 5
Li, W., Liu, T., Wu, T., Cai, T., Wang, F. W., & Zhang, M. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189492 · Cited by 5
Li, Z., Wang, Q., Wang, K., Zhang, W., & Ye, M. (2022) · PROTEOMICS · doi:10.1002/pmic.202100378 · Cited by 5
Gao, F., Chang, M., Xiang, M., Xu, H., Gnawali, G. R., Dong, Y., Lopez, B., & Wang, W. (2023) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.3c00246 · Cited by 5
Proteome-Wide Identification of Non-histone Lysine Methylation during Grape Berry Ripening
Pei, M., Liu, H., Wei, T., & Guo, D. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c03144 · Cited by 6
García, M. A., Fueyo, R., & Martínez‐Balbás, M. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802389-1.00010-1 · Cited by 5
Hamey, J. J., Hart‐Smith, G., Erce, M. A., & Wilkins, M. R. (2016) · FEBS Open Bio · doi:10.1002/2211-5463.12153 · Cited by 5
Epigenetic Approaches to Cancer Therapy
Saldanha, S. N., & Tollefsbol, T. O. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812215-0.00007-8 · Cited by 6
Berryhill, C. A., Evans, T. N., Doud, E. H., Smith-Kinnaman, W. R., Hanquier, J. N., Mosley, A. L., & Cornett, E. M. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00685 · Cited by 4
Zheng, Q., Qin, X., Huang, S., Yan, Z., Liu, J., Xiong, Y., Zhao, X., Ni, X., Mei, H., Jian, J., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103964 · Cited by 4
Nozaki, S., Naiki, T., Naiki‐Ito, A., Iwatsuki, S., Takeda, T., Etani, T., Nagai, T., Iida, K., Kato, H., Suzuki, T., et al. (2020) · Andrology · doi:10.1111/andr.12846 · Cited by 4
Nwajiobi, O., Mahesh, S., Streety, X. S., & Raj, M. (2020) · Angewandte Chemie · doi:10.1002/ange.202013997 · Cited by 4
Biggar, K. K., Ruiz‐Blanco, Y. B., Charih, F., Fang, Q., Connolly, J., Frensemier, K., Adhikary, H., Li, S. S. ‐., & Green, J. R. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · Cited by 4
Biggar, K. K., Charih, F., Liu, H., Ruiz‐Blanco, Y. B., Stalker, L., Chopra, A., Connolly, J., Adhikary, H., Frensemier, K., Galka, M., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/274688 · Cited by 4
NOP16 is a histone mimetic that regulates Histone H3K27 methylation and gene repressionPreprint
Takashima, K., Lee, D.-J., Trovero, M. F., Rothi, M. H., Mistry, M., Zhang, Y., Li, Z., Davis, C. P., Li, Z., Natale, J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.13.544862 · Cited by 4
Jin, G., Shi, Y., Sharma, S., & Liu, W. R. (2025) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5c00401 · Cited by 3
Loreti, M., Shi, D., & Carron, C. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010719 · Cited by 3
Protein Lysine Methyltransferases Inhibitors
Li, Y., Ding, L., Ren, S., Zhang, W., & Rao, G. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220829151257 · Cited by 3
Starska, K., Forma, E., Nowacka‐Zawisza, M., Lewy‐Trenda, I., Ciesielski, P., Pietruszewska, W., Skóra, M., & Bryś, M. (2015) · Tumor Biology · doi:10.1007/s13277-015-4276-3 · Cited by 3
Backbone resonance assignments for the SET domain of the human methyltransferase NSD2
Bobby, R., Peciak, K., & Milbradt, A. G. (2016) · Biomolecular NMR Assignments · doi:10.1007/s12104-016-9689-4 · Cited by 3
KDM3A catalyses the oxidation of acetyl-lysine to hydroxyacetyl-lysine on histone H3K9
Belle, R., Bukowski, J., Schiller, R., Cutler, R., Salah, E., Dawber, R. S., Tumber, A., Bonnici, J., Kindrick, J. D., Serrano, L., et al. (2026) · Nature Chemistry · doi:10.1038/s41557-026-02112-x · Cited by 2
Targeting SMYD2 improves immunotherapy response in experimental hepatocellular carcinoma
Bueloni, B., Fusco, M., Fiore, E. J., Malvicini, M., Cantero, M. J., Mauriz, L. L., Casadei, M., Ruiz, B. M., Mercogliano, M. F., Santamaría, E., et al. (2026) · Molecular Therapy Oncology · doi:10.1016/j.omton.2026.201239 · Cited by 2
Role of SMYD2 in gastrointestinal cancer progression (Review)
Xia, K., Zhou, Y., Xie, Y., & Cai, Y. (2025) · Oncology Letters · doi:10.3892/ol.2025.15028 · Cited by 2
Micallef, I., & Baron, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189038 · Cited by 3
Metadata
- Authors
- Hamamoto, R., Saloura, V., & Nakamura, Y.
- Affiliations
- University of Chicago (US)
- Corresponding author
- Hamamoto, Ryuji
- Venue
- Nature Reviews Cancer
- Published
- 2015-01-23
- Volume
- 15
- Issue
- 2
- Pages
- 110-124
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2036357556
- Cited by
- 376
- References
- 167
- Citations by year
- 2026: 14 · 2025: 20 · 2024: 27 · 2023: 29 · 2022: 36 · 2021: 30 · 2020: 39 · 2019: 38 · 2018: 33 · 2017: 38 · 2016: 49 · 2015: 22
- FWCI
- 4.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA modifications and cancer
- Keywords
- carcinogenesis, p53, RB1, STAT3, lysine methyltransferase, demethylases, cancer therapy targets, histone modifications
- MeSH terms
- Cell Transformation, Neoplastic, Chromosomal Proteins, Non-Histone, Humans, Lysine, Methylation, Histone-Lysine N-Methyltransferase, Tumor Suppressor Protein p53, Retinoblastoma Protein, STAT3 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review